Business News

EQRx Appoints Carlos Garcia-Echeverria, Ph.D., as Chief of Rx Creation

CAMBRIDGE, Mass.–()–EQRx, a company committed to developing and delivering important new medicines to patients at radically lower prices, today announced the appointment of Carlos Garcia-Echeverria, Ph.D., as chief of Rx creation. In this role, Carlos will be responsible for leading EQRx’s drug creation and early-stage research and development functions to continue to build a robust and sustainable pipeline of novel medicines.

“Carlos brings deep expertise across platforms, modalities and therapeutic categories, as well as his grounding in cutting-edge digital technologies, which further bolsters EQRx’s capability to realize the incredible potential of what’s possible through drug engineering,” said…

Click here to view the original article.

Related Posts

You might also like ...